2003

Jun 16, 2003
Guidant to Discontinue Product for Treating Abdominal Aortic Aneurysms

No Risk to Patients Implanted with ANCURE ENDOGRAFT System INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced plans to...

Jun 16, 2003
Guidant to Complete Acquisition of Innovative Device for Treatment of Coronary Artery Disease

X Technologies Receives FX miniRAIL U.S. Food and Drug Administration Approval; Conditions of X Technologies Acquisition Fulfilled; Agreement Expected to Close This Quarter Indianapolis, Ind. -...

Jun 13, 2003
Guidant to Host Conference Call

Company''s Management to Provide Update on Recent Developments Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...

Jun 12, 2003
EndoVascular Technologies Enters into Settlement with U.S. Department of Justice

No Risk to Patients Implanted with ANCURE ENDOGRAFT System INDIANAPOLIS - EndoVascular Technologies, Inc. (EVT), a subsidiary of Guidant Corporation, today announced that it has entered into a...

Jun 10, 2003
Guidant Leads Clinical Investigation of New Therapy for Stroke Prevention

Second Clinical Trial Advances Efforts to Develop Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world...

Show 5102550100 per page
Top